ThomasH.BrannaganIIIMD

Neuromuscular Medicine, Neurophysiology

Professor of Neurology, Columbia P&S

Overview of Dr. Brannagan

Dr. Thomas Brannagan is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Virginia School of Medicine and has been in practice 27 years. Dr. Brannagan accepts several types of health insurance, listed below. He is one of 482 doctors at New York-Presbyterian Hospital and one of 211 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurology. He has more than 100 publications and over 500 citings.

Office
710 West 168th Street
New York, NY 10032
Book by Phone+1(928) 756-8313

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1991 - 1994
Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine, 1990 - 1991
University of Virginia School of MedicineClass of 1990

Certifications & Licensure

FL State Medical License 2021 - Present
CT State Medical License 2022 - 2025
NJ State Medical License 2022 - 2025
NY State Medical License 1993 - 2025
PA State Medical License 1997 - 2002
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Clinical Neurophysiology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Clinical Trials

An Open Label, Dose Finding Trial of Viagra for the Treatment of Neuropathic Pain (in Diabetes Mellitus) Start of enrollment: 2004 Aug 01
Completed
Phase 4
A Placebo Controlled, Randomized, Double Blind Trial of Milnacipran for the Treatment of Idiopathic Neuropathy Pain Start of enrollment: 2011 Apr 05
Terminated
Phase 3
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy Start of enrollment: 2013 Mar 15
Completed
Phase 2, Phase 3

Publications & Presentations

PubMed

Electrodiagnostic subtyping in Guillain-Barré syndrome patients in the International Guillain-Barré Outcome Study.
Samuel Arends, Judith Drenthen, Laura de Koning, Peter van den Bergh, Robert D M Hadden
European Journal of Neurology. 2024-09-01
2 citations
Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials.
Norman Latov, Thomas H Brannagan 3rd, Howard W Sander, Francisco de Assis Aquino Gondim
Arquivos De Neuro-Psiquiatria. 2024-06-01
Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A.
Shahram Attarian, Peter Young, Thomas H Brannagan, David Adams, Philip Van Damme
Orphanet Journal of Rare Diseases. 2024-04-01

Lectures

hATTR Amyloidosis with Polyneuropathy: A Patient’s Journey to Treatment
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Press Mentions

New Long-Term TEGSEDI Safety and Efficacy Data Featured as an Oral Presentation at 2019 American Academy of Neurology Annual Meeting (AAN)May 7th, 2019
Nationwide, the Shortage of Immunoglobulin Is Impacting Practice: How Neurologists Are Managing ItOctober 24th, 2019

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
Great West PPO
Healthfirst New York
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment